Clinical Trial Update: The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

View source ↗

Summary

This clinical trial study assesses the immunogenicity of the quadrivalent HPV vaccine (types 6, 11, 16, and 18) in patients with chronic kidney disease (Stage I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Chulalongkorn University | Conditions: Chronic Kidney Disease, Stage IV (Severe), Chronic Kidney Disease, Stage V | Status: UNKNOWN